Every solid-phase peptide synthesis is a race between the acylating reagent and the growing chain's own tendency to fold. For most sequences the reagent wins comfortably and each cycle runs to something close to completion. For a minority — the ones the field has called difficult sequences for decades — it does not, and the failure is not a reagent-quality problem or an operator problem. It is a conformational problem, and it has to be solved conformationally. A protocol paper for Fmoc/tBu synthesis states the position bluntly: aggregation of the growing peptide chain is the main cause of failure for peptide chemosynthesis, and special techniques have to be applied to reduce it [1].

What on-resin aggregation actually is

A synthesis resin is not a surface with peptides standing on it. It is a swollen polymer gel with chains distributed through its interior at high local concentration, each one tethered by its C-terminus and free to move only so far. The backbone amide of a peptide is both a hydrogen-bond donor and an acceptor. Once enough residues have accumulated, neighboring chains — or distant parts of the same chain — can satisfy those hydrogen bonds against each other in the regular, repeating pattern of a β-sheet. What happens next is mechanical rather than chemical: the sheet is a dense, poorly solvated domain, and the N-terminal α-amino group that needs to be acylated ends up inside it. Reagent cannot reach the amine, and the base used to remove the temporary Fmoc group cannot reach the carbamate either. Neither step gets intrinsically slower in a chemical sense; the reactive group simply stops being available.

That distinction matters because it predicts which fixes work. If the amine is physically shielded rather than chemically deactivated, adding more coupling reagent or extending the coupling time addresses a step that is not the limiting one, and a change in conformation is the intervention this picture points to.

One early and direct piece of evidence for the conformational picture came from watching a difficult coupling develop. During the solid-phase synthesis of a 32-residue growth hormone releasing factor analog, incorporation of one residue at position 16 was found to be incomplete, and nothing in the local sequence explained it. The authors recorded 500 MHz proton NMR spectra of a series of resin-bound segments of increasing length, swollen in deuterated dimethyl sulfoxide. Spectra of the shortest segment were relatively sharp; components broadened by an order of magnitude appeared in the next two longer segments; the spectrum of the segment beginning at position 16 was ill-resolved and highly broadened throughout. Then, as assembly continued past that point, the spectra sharpened again. Together with secondary-structure predictions, the authors suggest that completeness of the position-16 coupling is hindered by formation of a specific folded β-sheet/β-turn structure, with the turn located at positions 18 to 21, upstream of the difficult coupling site itself [2].

Two lessons sit in that result. The onset is abrupt — a synthesis can be uneventful for fifteen cycles and then fall over in one. And the structure that causes the trouble is not necessarily at the position where the trouble appears; it can be built from residues already installed, several positions away.

Why some sequences and not others

Aggregation is sequence-dependent, but the dependence is not reducible to a simple rule. Chain length is one axis: a review of the depsipeptide approach notes that folding and aggregation limit chemosynthesis not only above a critical length, but also for relatively short sequences that form highly folded structures or that assemble into fibrils after final deprotection [3]. Composition is another. Long runs of small residues are a recognized hazard — a 23-mer homopolymer of alanine has been used as a deliberate stress test for backbone-protection chemistry, alongside the classic difficult decapeptide from acyl carrier protein, residues 65 to 74 [4].

Predictive tools should be treated as advisory. A glycine-rich 32-residue fragment of the spider protein acanthoscurrin was undertaken with the stated aim of contributing to knowledge of the secondary structure and stepwise solid-phase synthesis of glycine-rich domains; although a theoretical prediction did not indicate high aggregation potential for it, repetitive incomplete acylations were observed after one specific residue. Near-infrared FT-Raman spectra collected on the growing peptide-resin revealed β-sheet structures, and did so on all three supports tested. The authors report that changing coupling reagents, changing solvents, adding chaotropic salts, and switching resin and protecting-group strategy did not solve the problem on their own; only a combination of a further resin change, elevated temperature, a backbone-protected glycine derivative and lithium chloride — the last two applied alternately — inhibited the phenomenon [5]. That is a single sequence and should not be generalized into a recipe, but it is a fair picture of how stubborn a genuinely difficult stretch can be.

Pseudoprolines: a proline that is not permanent

Proline residues interrupt β-sheets because a proline nitrogen carries no amide hydrogen to donate and the ring constrains the backbone. Pseudoprolines exploit that without permanently altering the sequence. Serine and threonine side chains are condensed with a carbonyl compound to form an oxazolidine ring, and cysteine gives the corresponding thiazolidine; the ring is a temporary side-chain protection that, while present, makes the residue behave like a proline. These building blocks were introduced for standard Fmoc/tBu synthesis and are incorporated by coupling preformed, suitably protected pseudoproline dipeptides, an arrangement that sidesteps the difficulty of acylating the hindered ring nitrogen on the resin. The original report demonstrated, for model peptides used in protein de novo design, the potential of pseudoprolines to solubilize otherwise sparingly or completely insoluble peptides, and described the building blocks as having an intrinsic propensity for preventing peptide aggregation and β-sheet formation [6]. The ring is opened and the native serine, threonine or cysteine regenerated during the acid cleavage step, so nothing has to be removed separately afterwards.

The effect on real syntheses can be categorical rather than incremental. In the Fmoc synthesis of the 37-residue human amylin sequence and its 8–37 fragment, syntheses of the 8–37 fragment using ordinary Fmoc amino acids produced only traces of the desired peptide, whereas incorporation of pseudoproline dipeptides produced the desired product with high yield and allowed synthesis of the full-length peptide; the crude material was pure enough to allow formation of the disulfide by air oxidation [7].

A second report frames the mechanism in terms the analyst can use: pseudoproline derivatives disrupt the interactions among chains that are usually the cause of poor coupling yields in aggregated sequences. Combining them with a fully poly(ethylene glycol)-based resin allowed an efficient stepwise synthesis of a 68-residue chemokine that the authors describe as complex and aggregated [8]. A similar combination — the same poly(ethylene glycol)-based resin [8], which this second group describes as known to decrease chain aggregation, plus pseudoproline dipeptides at selected positions — converted a problematic 32-residue three-disulfide sequence into material pure enough to fold in situ without an intermediate purification step [9].

The limitation is structural: the strategy needs serine, threonine or cysteine at usable spacing. A recent methods paper states the constraint directly, noting that pseudoprolines are limited to serine-, threonine- and cysteine-rich peptide segments, and that aggregation and solubility still restrict routine solid-phase access to peptides longer than about 40 amino acids [10].

Backbone amide protection

Where the sequence offers no hydroxyl or thiol to work with, the alternative is to protect the backbone nitrogen itself. Attaching a substituted benzyl group to an amide nitrogen removes that donor from the hydrogen-bonding network entirely. The 2-hydroxy-4-methoxybenzyl (Hmb) group is one such auxiliary; the rationale stated for it is that aggregation due to hydrogen-bond interchain association is inhibited [11].

The chemical cost is obvious: the residue following a protected nitrogen has to be coupled onto a hindered secondary amine, and the group then has to come off cleanly at the end. Successive auxiliaries have been designed around those two steps rather than around the aggregation itself.

  • Internal acyl transfer. The 2-hydroxy group is not decorative. In the 2-hydroxy-4-methoxy-5-nitrobenzyl (Hmnb) auxiliary, acylation of the hindered secondary amine is aided by formation of an internal nitrophenol ester that undergoes a favorable intramolecular O-to-N acyl transfer; this activated ester participates in the coupling and, the authors report, generally gives complete reaction under standard coupling conditions. Hmnb is introduced during assembly by adding an aldehyde to the peptidyl-resin followed by on-resin reduction to the secondary amine, and is demonstrated on the acyl carrier protein decapeptide and on the polyalanine 23-mer [4].
  • Steric scope. An earlier study of o-hydroxyl-substituted nitrobenzyl (Hnb) auxiliaries compared acyl transfer efficiency against Hmb across protected amino acids of varying size and found Hnb superior, with the difference more pronounced for the more sterically demanding amino acids. That auxiliary is incorporated by reductive alkylation on the resin and removed by mild photolysis at 366 nm [12].
  • Removal. Benzyl-type groups can be difficult to remove after assembly. A tetrahydropyranyl (Thp) group has been evaluated as a more acid-labile alternative that is introduced as a protected dipeptide and is readily cleaved and scavenged post-synthesis; the authors report a drastic improvement in solid-phase assembly of aggregation-prone amyloid-beta and prion-derived peptide fragments [10].

The depsipeptide, or O-acyl isopeptide, route

A third strategy breaks the backbone rather than decorating it. At a serine or threonine, the native amide bond is replaced during assembly by an ester to the side-chain hydroxyl, so the chain runs through an oxygen instead of a nitrogen at that point. One backbone hydrogen-bond donor disappears, and the resulting ester isomers are, in the words of one review, often easier to assemble and purify, and are smoothly converted to the parent amides under mild conditions. The method is applicable to sequences containing serine or threonine [3]. The protocol paper cited at the top of this guide demonstrates depsipeptide and pseudoproline units together on a sequence the authors describe as impossible to obtain using their standard protocol [1].

How the failure shows up in the product

None of this would matter analytically if a failed coupling stopped the synthesis. It does not. A chain whose amine was shielded during one coupling is deprotected in the next cycle along with everything else and rejoins the elongation, one residue short. The result is a deletion sequence: full-length in every respect except that an internal residue is absent. Its mass is the target's minus the residue mass of what never went in — 57.02 Da monoisotopic for a missing glycine, 71.04 Da for an alanine. Capping unreacted amines after a coupling converts these into shortened truncation fragments instead, on the reasoning that a fragment of clearly different length and hydrophobicity is easier to resolve chromatographically than a full-length peptide missing one small residue.

The arithmetic is worth doing because aggregation does not degrade one coupling, it degrades a window of them. Consider four consecutive cycles inside an aggregated stretch, each proceeding to 95%, with no capping. The fraction of chains that come through all four intact is 0.95 to the fourth power, or 81.45%, so 18.55% of chains carry at least one deletion from that window alone. Run the same four cycles at 99.5% and 98.01% survive, leaving 1.99% deleted. Both numbers are illustrative rather than measured, and the denominator in each case is all chains on the resin, not the isolated yield. The point is the leverage: the difference between an ordinary stretch and a difficult one is four cycles wide and roughly ninefold in deletion burden.

In-process colorimetric tests report the bead population in bulk and are therefore weak at exactly the moment they are most needed, since a partially aggregated resin can present a small free-amine signal that reads as noise. Sampling and analyzing the chain is more informative. One optimization of a difficult sequence monitored elongation by mini-cleavage and mass spectrometry at strategic points, specifically to identify the problematic spots and act on them [9]. On the physical side, spectroscopy of the peptide-resin itself — the NMR line broadening described above [2], or the FT-Raman band assignments used for the glycine-rich fragment [5] — detects the sheet directly rather than inferring it from yield.

What is not settled

Backbone protection is often described as structure-breaking, but the description is not absolute. When Hmb groups were installed at five glycine positions of a 40-residue amyloid-beta peptide and the protected peptide examined in solution, comparative structural studies by circular dichroism and gel electrophoresis found it to adopt both α-helix and intermolecular β-sheet conformations, and to form β-sheet structures in aqueous buffer, despite the reported structure-breaking activity of the group; gel electrophoresis did indicate that, unlike the unprotected peptide, it did not form large aggregate species [13]. That study examined the cleaved peptide in solution rather than the resin-bound chain, so it does not directly measure on-resin behavior — but it argues against treating backbone protection as an abolition of secondary structure rather than a perturbation of it.

Two other honest gaps. No source reviewed here supplies a reliable a priori predictor of which sequences will aggregate on a given resin in a given solvent; the acanthoscurrin case is a documented instance of a prediction not flagging a sequence that turned out to be difficult [5]. And head-to-head comparisons of pseudoproline, backbone-protection and depsipeptide strategies on the same sequence, under the same conditions, are uncommon in the sources reviewed here, so claims that one approach is generally superior to another should be read as preferences rather than as demonstrated rankings.